Trastuzumab has become part of the standard of care for the treatment of patients with HER2-positive breast cancer in the metastatic as well as the adjuvant setting. Cardiotoxicity, however ...

New drugs and therapies have become indispensable for treating an array of cancers. Unfortunately, they can also cause damage to the heart, a side effect that has led to the development of a new ...

Triplet therapy using darolutamide vs abiraterone plus prednisone may lead to less cardiotoxicity in patients with metastatic hormone-sensitive prostate cancer (mHSPC). Steven Canfield ...

"It might sound counter-intuitive to exercise while undergoing treatment for cancer, but we've found that intervening ...

Also, the PRADA II (prevention of cardiac dysfunction during adjuvant breast cancer therapy) trial is a randomized, placebo-controlled study of [Entresto]/[Diovan] in in prevention of cardiotoxicity ...

Health experts want blood- and breast-cancer patients prescribed exercise to mitigate heart damage during treatment.

Tumor-cell heterogeneity has represented a major obstacle to the development of CAR T-cell therapy for solid tumors, said ...

“People with diabetes undergoing cancer treatment may face specific challenges ... also have damaging effects on the heart, known as cardiotoxicity. People with diabetes already carry an ...

Researchers advance CAR T cell therapy for solid tumors by innovating ways to overcome the unique barriers of solid tumor ...

A guideline panel indirectly studied cardiotoxicity among advanced prostate cancer treatments (mHSPC, mCRPC, CRPC).